Literature DB >> 2152856

FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation.

N H Dang1, D A Hafler, S F Schlossman, J B Breitmeyer.   

Abstract

Ta1 (CDw26) is a 105-kDa glycoprotein of unknown function whose expression on human T lymphocytes is strongly correlated with activation and proliferation. The subset of peripheral blood T cells expressing Ta1 includes the principal responsive population to proliferative stimulation by recall antigens as well as monoclonal antibodies directed to the CD3/T cell receptor complex and the CD2 (T11) molecule. We now show that the Ta1 molecule is itself an alternate mediator of human T lymphocyte activation. T cell clones were induced to proliferate and exert their cytolytic effector function by anti-Ta1 monoclonal antibodies in the presence of Fc-receptor-positive accessory or target cells. Resting T cells from peripheral blood were also activated to proliferate by anti-Ta1, but only if both Fc-receptor-positive accessory cells and exogenous IL-2 were present. Anti-Ta1 antibodies induced increased expression of IL-2 receptors on purified T cells under these conditions. Activation via Ta1 was shown to be functionally interconnected to CD3/T cell receptor activation mechanisms, because modulation of the CD3/T cell receptor complex inhibited anti-Ta1-mediated cytolysis without affecting Ta1 surface expression. While demonstrating that the CDw26 antigen-mediated pathway of activation is not dependent on one unique epitope, our results suggest that the Ta1 glycoprotein can mediate T cell activation directly, suggesting that it may be associated with an important cellular component of the human T cell regulatory network.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2152856     DOI: 10.1016/0008-8749(90)90061-u

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  7 in total

1.  Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity.

Authors:  U Fiocco; M Rosada; L Cozzi; C Ortolani; G De Silvestro; A Ruffatti; E Cozzi; C Gallo; S Todesco
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

2.  The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.

Authors:  T Tanaka; J Kameoka; A Yaron; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

3.  Immunological markers among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  W Halperin; R Vogt; M H Sweeney; G Shopp; M Fingerhut; M Petersen
Journal:  Occup Environ Med       Date:  1998-11       Impact factor: 4.402

4.  Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding protein.

Authors:  B Hardy; M Galli; E Rivlin; L Goren; A Novogrodsky
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968

5.  Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors.

Authors:  U Aytac; K Sato; T Yamochi; T Yamochi; K Ohnuma; G B Mills; C Morimoto; N H Dang
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

6.  CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors.

Authors:  K Sato; U Aytac; T Yamochi; T Yamochi; K Ohnuma; K S McKee; C Morimoto; N H Dang
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

Review 7.  The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis.

Authors:  Yannick Waumans; Lesley Baerts; Kaat Kehoe; Anne-Marie Lambeir; Ingrid De Meester
Journal:  Front Immunol       Date:  2015-08-07       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.